Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T07:10:59.300Z Has data issue: false hasContentIssue false
  • English
  • Français

Executive deficits in psychotic and bipolar disorders – Implications for our understanding of schizoaffective disorder

Published online by Cambridge University Press:  16 April 2020

Andrei Szoke ,
Alexandre Meary ,
Anca Trandafir ,
Frank Bellivier ,
Isabelle Roy ,
Franck Schurhoff  and
Marion Leboyer
Andrei Szoke*
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
Alexandre Meary
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
Anca Trandafir
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France
Frank Bellivier
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
Isabelle Roy
Affiliation:
AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
Franck Schurhoff
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
Marion Leboyer
Affiliation:
INSERM, U 841, F-94000Creèteil, France Universiteè Paris 12, Faculteè de Meèdecine, CreèteilF-94000, France AP-HP, GHU “Albert Chenevier e Henri Mondor”, Poôle de Psychiatrie, CreèteilF-94000, France
*
*Corresponding author. Service de Psychiatrie, Hôpital Albert Chenevier, 40 rue de Mesly, F-94000 Créteil, France. Tel.: +33 (0) 1 49 81 30 51; fax: +33 (0) 1 49 81 30 59.
Get access

Abstract

Objective

Schizoaffective disorder could be considered as a form of schizophrenia, a form of bipolar disorder, an independent disorder or a disorder intermediate between bipolar disorder and schizophrenia, within a psychotic continuum. The study of cognitive deficits in subjects with those diagnoses could help differentiate between these possibilities.

Methods

We compared cognitive performances of schizoaffective (SZAff) subjects with those of subjects with schizophrenia (SZ), bipolar disorder with psychotic symptoms (life-time) (BDP), bipolar disorder without life-time occurrence of psychotic symptoms (BD) and normal controls (NC). We used two tests of executive functions – the Wisconsin Card Sorting Test (WCST) and the Trail-making Test (TMT) – that are known to be impaired in those disorders.

Results

The number of perseverative errors on WCST was highest in SZ subjects and gradually decreased in SZAff, BDP and, finally in BD subjects. By contrast, SZ and SZAff subjects obtained similar scores in the TMT, as did BD and BDP patients.

Conclusions

These results suggest that, for some deficits, there may be a continuum between SZ, SZAff and affective disorders, whereas SZAff patients most closely resemble SZ patients for other deficits. This implies that different conceptual views about schizoaffective disorder should be seen as complementary, rather than mutually exclusive.

Keywords

SchizophreniaSchizophrenia and psychosisSchizoaffective disorderAffective disordersCognitionPsychometry and assessments in psychiatry
Type
Original articles
Information
European Psychiatry , Volume 23 , Issue 1 , January 2008 , pp. 20 - 25
Copyright
Copyright © Elsevier Masson SAS 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed.Washington, DC: American Psychiatric Press; 1994.Google Scholar
Arnett, J.A., Labovitz, S.S.Effects of physical layout in performance of the trail making test. Psychol Assess 1995;7:220–221.CrossRefGoogle Scholar
Beatty, W.W., Jocic, Z., Monson, N., Staton, R.D.Memory and frontal lobe dysfunction in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 1993;181:448–453.CrossRefGoogle ScholarPubMed
Bech, P., Bolwig, T.G., Kramp, P., Rafaelsen, O.J.The Bech–Rafaelsen mania scale and the Hamilton depression scale. Acta Psychiatr Scand 1979;59:420–430.CrossRefGoogle ScholarPubMed
Bornstein, R.A., Nasrallah, H.A., Olson, S.C., Coffman, J.A., Torello, M., Schwarzkopf, S.B.Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid and schizoaffective subgroups. Psychiatry Res 1990;31:15–24.CrossRefGoogle ScholarPubMed
Daban, C., Martinez-Aran, A., Torrent, C., Tabares-Seisdedos, R., Balanza-Martinez, V., Salazar-Fraile, J.et al.Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother Psychosom 2006;75:72–84.CrossRefGoogle ScholarPubMed
Donaldson, S., Goldstein, L.H., Landau, S., Raymont, V., Frangou, S.The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003;64:86–93.CrossRefGoogle ScholarPubMed
Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E.et al.Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917–6922.CrossRefGoogle ScholarPubMed
Evans, J.D., Heaton, R.K., Paulsen, J.S., McAdams, L.A., Heaton, S.C., Jeste, D.V.Schizoaffective disorder: a form of schizophrenia or affective disorder?. J Clin Psychiatry 1999;60:874–882.CrossRefGoogle ScholarPubMed
Gilvarry, C.M., Russell, A., Jones, P., Sham, P., Hemsley, D., Murray, R.M.Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives. Psychol Med 2001;31:695–704.CrossRefGoogle ScholarPubMed
Glahn, D.C., Bearden, C.E., Cakir, S., Barrett, J.A., Najt, P., Serap Monkul, E.et al.Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006;8:117–123.CrossRefGoogle ScholarPubMed
Glahn, D.C., Bearden, C.E., Niendam, T.A., Escamilla, M.A.The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004;6:171–182.CrossRefGoogle ScholarPubMed
Goldstein, G., Shemansky, W.J., Allen, D.N.Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Arch Clin Neuropsychol 2005;20:153–159.CrossRefGoogle ScholarPubMed
Gooding, D.C., Tallent, K.A.Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders?. Schizophr Res 2002;53:209–218.CrossRefGoogle ScholarPubMed
Heaton, R.The Wisconsin Card Sorting Test manual. Odessa, FL: Psychological Assessment Resources; 1981.Google Scholar
Heinrichs, R.W.The primacy of cognition in schizophrenia. Am Psychologist 2005;60:229–242.CrossRefGoogle ScholarPubMed
Heinrichs, R.W., Zakzanis, K.K.Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998;12:426–445.CrossRefGoogle Scholar
Jeste, D.V., Heaton, S.C., Paulsen, J.S., Ercoli, L., Harris, J., Heaton, R.K.Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. Am J Psychiatry 1996;153:490–496.Google Scholar
Keefe, R.S., Silva, S.G., Perkins, D.O., Lieberman, J.A.The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999;25:201–222.CrossRefGoogle ScholarPubMed
Ketter, T.A., Wang, P.W., Becker, O.V., Nowakowska, C., Yang, Y.Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?. J Psychiatr Res 2004;38:47–61.CrossRefGoogle ScholarPubMed
Krabbendam, L., Marcelis, M., Delespaul, P., Jolles, J., van Os, J.Single or multiple familial cognitive risk factors in schizophrenia?. Am J Med Genet 2001;105:183–188.CrossRefGoogle ScholarPubMed
Lake, C.R., Hurwitz, N.Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders. Psychiatry Res 2006;143:255–287.CrossRefGoogle ScholarPubMed
Laws, K.A meta-analytic review of wisconsin card sort studies in schizophrenia: general intellectual deficit in disguise?. Cognit Neuropsychiatry 1999;4:1–35.CrossRefGoogle ScholarPubMed
Lezak, M.D.Neuropsychological assessment. 3rd ed.Oxford: Oxford University Press; 1995.Google Scholar
Maxwell, M.E. Family interview for genetic studies. Clinical Neurogenetic Branch, Intramural Research Program, NIMH; 1992.Google Scholar
Meador, K.J.Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry 2003;64(Suppl. 8):30–34.Google ScholarPubMed
Miller, L.S., Swanson-Green, T., Moses, J.A., Faustman, W.O.Comparison of cognitive performance in RDC-diagnosed schizoaffective and schizophrenic patients with the Luria-Nebraska Neuropsychological Battery. J Psychiatr Res 1996;30:277–282.CrossRefGoogle ScholarPubMed
Montgomery, S.A., Asberg, M.A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.CrossRefGoogle ScholarPubMed
Nurnberger, J.I., Blehar, M.C., Kaufmann, C.A., York-Cooler, C., Simpson, S.G., Harkavy-Friedman, J.et al.Diagnostic interview of genetic studies: rationale, unique features and training. Arch Gen Psychiatry 1994;51:249–259.CrossRefGoogle ScholarPubMed
Pachet, A.K., Wisniewski, A.M.The effects of lithium on cognition: an updated review. Psychopharmacology (Berl) 2003;170:225–234.CrossRefGoogle Scholar
Pichot, P., Lebeaux, M.O., Penhouët, C., Simon, M.L'estimation du niveau intellectuel prémorbide à la WAIS-R. Comparaison entre la méthode de Barona et l'Index de détérioration de Wechsler. Rev Eur Psychol Appl 1993;43:291–301.Google Scholar
Preisig, M., Fenton, B.T., Matthey, M.L., Berney, A., Ferrero, F.Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci 1999;249:174–179.CrossRefGoogle ScholarPubMed
Reitan, R.M., Wolfson, D.The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation Tucson, AZ: Neuropsychology Press; 1985.Google Scholar
Robinson, L.J., Thompson, J.M., Gallagher, P., Goswami, U., Young, A.H., Ferrier, I.N.et al.A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006;93:105–115.CrossRefGoogle ScholarPubMed
Rund, B.R.A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998;24:425–435.CrossRefGoogle ScholarPubMed
Schwartz, J.E., Fennig, S., Tanenberg-Karant, M., Carlson, G., Craig, T., Galambos, N.et al.Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000;57:593–600.CrossRefGoogle Scholar
Seidman, L.J., Cassens, G., Kremen, W.S., Pepple, J.R.The neuropsychology of schizophrenia. White, R.F.Clinical syndromes in adult neuropsychology: the practitioner's handbook Amsterdam: Elsevier; 1992. p. 381–445.Google Scholar
Spohn, H.E., Strauss, M.E.Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989;98:367–380.CrossRefGoogle Scholar
Stip, E., Dufresne, J., Lussier, I., Yatham, L.A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Affect Disord 2000;60:147–157.CrossRefGoogle ScholarPubMed
Stip, E., Sepehry, A.A., Prouteau, A., Briand, C., Nicole, L., Lalonde, P.et al.Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain Cogn 2005;59:292–295.CrossRefGoogle ScholarPubMed
Woodward, N.D., Purdon, S.E., Meltzer, H.Y., Zald, D.H.A meta-analysis of neuropsychological change to clozapine, olanzapine, quetapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 2005;8:457–472.CrossRefGoogle Scholar
Yurgelun-Todd, D.A., Kinney, D.K.Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects. J Neuropsychiatry Clin Neurosci 1993;5:294–300.Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.